UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	May 13, 2008

Accession Number:	0001193125-08-100901
Submission Type:	POS AM
CIK: 0000822411 Company Name: ImmunoCellular Therapeutics, Ltd. File Number: 333-144521